TD Cowen reiterated a Buy rating for Boston Scientific (NYSE:BSX) stock, maintaining a price target of $110.00. The stock, currently trading at $98.78, has shown remarkable momentum, reaching new ...

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 ...

Boston Celtics vs. Golden State Warriors in the NBA starts at 5 p.m. ET on Jan. 20. This game takes place at Chase Center in ...

The most recent trading session ended with Boston Scientific (BSX) standing at $98.66, reflecting a +0.5% shift from the previouse trading day's closing. The stock lagged the S&P 500's daily gain of 1 ...

Jan. 16 (UPI) --The U.S. Food and Drug Administration on Thursday approved the marketing of Zyn nicotine pouch products after undertaking an extensive scientific review of them. The American Lung ...

Sequent Scientific Ltd., incorporated in the year 1985, is a Small Cap company (having a market cap of Rs 4,321.51 Crore) operating in Pharmaceuticals sector. Sequent Scientific Ltd. key ...

After hours: January 17 at 4:00:08 PM EST Loading Chart for KEQU ...

The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...